BIOX Stock Analysis: Buy, Sell, or Hold?
BIOX - Bioceres Crop Solutions Corp. Ordinary Shares
$0.42
0.00 (-0.80%)
âŧ
5d:
-0.02%
30d:
+10.29%
90d:
-1.41%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 14, 2026
TODAY
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BIOX is fairly priced but lacks strong directional signals. At -8.3% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BIOX is fairly priced but lacks strong directional signals. At -8.3% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.42, which is considered fair relative to its 30-day fair value range of $0.38 to $0.44. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.4) compared to its historical average (10.9). Remarkably, the market is currently pricing in an annual earnings decline of 8.3% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a downtrend. Immediate support is located at $0.40, while resistance sits at $0.57.
Market Sentiment: BIOX scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+377.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOX is in a downtrend. Immediate support is located at $0.40, while resistance sits at $0.57.
Market Sentiment: BIOX scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+377.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.38 -
$0.44
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 377.2% below Wall St target ($2.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.40
Resistance Level
$0.57
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.38
Wall Street Target
$2.00
(+377.2%)
Revenue Growth (YoY)
-35.9%
Earnings Growth (YoY)
34.4%
Profit Margin
-17.7%
Valuation Discount vs History
-8.3% cheaper
PE vs Historical
8.4 vs 10.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.3%
(market-implied from PE analysis)
1-Year Target
$0.38
(-8%)
2-Year Target
$0.35
(-16%)
3-Year Target
$0.32
(-23%)
3-Yr Target (if PE normalizes)
(PE: 8â11)
$0.42
(+0%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 10.9
Stabilization Target:
$0.55
(+30.0%)
PE Expansion Potential:
+30.0%
Share & Embed Analysis
Last updated: September 13, 2026 10:08 AM ET
Data refreshes hourly during market hours. Next update: 11:08 AM
Data refreshes hourly during market hours. Next update: 11:08 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CTVA
Corteva Inc |
STRONG BUY
24 analysts |
$92 | 45 HOLD |
|
NTR
Nutrien Ltd |
STRONG BUY
24 analysts |
$77 | 32 SELL |
|
MOS
The Mosaic Company |
BUY
20 analysts |
$27 | 34 SELL |
|
SMG
Scotts Miracle-Gro CompaâĻ |
STRONG BUY
11 analysts |
$77 | 41 HOLD |
|
FMC
FMC Corporation |
HOLD
20 analysts |
$14 | 33 SELL |
